Literature DB >> 10751364

Cystic fibrosis transmembrane conductance regulator does not affect neutrophil migration across cystic fibrosis airway epithelial monolayers.

L Pizurki1, M A Morris, M Chanson, M Solomon, A Pavirani, I Bouchardy, S Suter.   

Abstract

Recent studies have shown that airway inflammation dominated by neutrophils, ie, polymorphonuclear cells (PMN) was observed in infants and children with cystic fibrosis (CF) even in the absence of detectable infection. To assess whether there is a CF-related anomaly of PMN migration across airway epithelial cells, we developed an in vitro model of chemotactic migration across tight and polarized CF(15) cells, a CF human nasal epithelial cell line, seeded on porous filters. To compare PMN migration across a pair of CF and control monolayers in the physiological direction, inverted CF(15) cells were infected with increasing concentrations of recombinant adenoviruses containing either the normal cystic fibrosis transmembrane conductance regulator (CFTR) cDNA, the DeltaF508 CFTR cDNA, or the beta-galactosidase gene. The number of PMN migrating in response to N-formyl-Met-Leu-Phe across inverted CF(15) monolayers expressing beta-galactosidase was similar to that seen across CF(15) monolayers rescued with CFTR, whatever the proportion of cells expressing the transgene. Moreover, PMN migration across monolayers expressing various amounts of mutated CFTR was not different from that observed across matched counterparts expressing normal CFTR. Finally, PMN migration in response to adherent or Pseudomonas aeruginosa was equivalent across CF and corrected monolayers. The possibility that mutated CFTR may exert indirect effects on PMN recruitment, via an abnormal production of the chemotactic cytokine interleukin-8, was also explored. Apical and basolateral production of interleukin-8 by polarized CF cells expressing mutated CFTR was not different from that observed with rescued cells, either in baseline or stimulated conditions. CF(15) cells displayed a CF phenotype that could be corrected by CFTR-containing adenoviruses, because two known CF defects, Cl(-) secretion and increased P. aeruginosa adherence, were normalized after infection with those viruses. Thus, we conclude that the presence of a mutated CFTR does not per se lead to an exaggerated inflammatory response of CF surface epithelial cells in the absence or presence of a bacterial infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10751364      PMCID: PMC1876904          DOI: 10.1016/S0002-9440(10)65009-2

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  32 in total

1.  Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis.

Authors:  T L Noah; H R Black; P W Cheng; R E Wood; M W Leigh
Journal:  J Infect Dis       Date:  1997-03       Impact factor: 5.226

2.  Transmigration of human neutrophils across airway epithelial cell monolayers is preferentially in the physiologic basolateral-to-apical direction.

Authors:  L Liu; F P Mul; R Lutter; D Roos; E F Knol
Journal:  Am J Respir Cell Mol Biol       Date:  1996-12       Impact factor: 6.914

3.  Intestinal epithelial cytoskeleton selectively constrains lumen-to-tissue migration of neutrophils.

Authors:  P Hofman; L D'Andrea; D Carnes; S P Colgan; J L Madara
Journal:  Am J Physiol       Date:  1996-07

4.  Selective up-regulation of chemokine IL-8 expression in cystic fibrosis bronchial gland cells in vivo and in vitro.

Authors:  O Tabary; J M Zahm; J Hinnrasky; J P Couetil; P Cornillet; M Guenounou; D Gaillard; E Puchelle; J Jacquot
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

5.  In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted.

Authors:  M Lusky; M Christ; K Rittner; A Dieterle; D Dreyer; B Mourot; H Schultz; F Stoeckel; A Pavirani; M Mehtali
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

6.  Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli.

Authors:  C Chartier; E Degryse; M Gantzer; A Dieterle; A Pavirani; M Mehtali
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

7.  Lower airway inflammation in infants and young children with cystic fibrosis.

Authors:  D S Armstrong; K Grimwood; J B Carlin; R Carzino; J P Gutièrrez; J Hull; A Olinsky; E M Phelan; C F Robertson; P D Phelan
Journal:  Am J Respir Crit Care Med       Date:  1997-10       Impact factor: 21.405

8.  Neutrophil transepithelial migration is dependent upon epithelial characteristics.

Authors:  E J Carolan; T B Casale
Journal:  Am J Respir Cell Mol Biol       Date:  1996-08       Impact factor: 6.914

9.  Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells.

Authors:  E DiMango; A J Ratner; R Bryan; S Tabibi; A Prince
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

10.  Interleukin-8 production by cystic fibrosis nasal epithelial cells after tumor necrosis factor-alpha and respiratory syncytial virus stimulation.

Authors:  H R Black; J R Yankaskas; L G Johnson; T L Noah
Journal:  Am J Respir Cell Mol Biol       Date:  1998-08       Impact factor: 6.914

View more
  15 in total

1.  CFTR is a pattern recognition molecule that extracts Pseudomonas aeruginosa LPS from the outer membrane into epithelial cells and activates NF-kappa B translocation.

Authors:  Torsten H Schroeder; Martin M Lee; Patrick W Yacono; Carolyn L Cannon; A Alev Gerçeker; David E Golan; Gerald B Pier
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-07       Impact factor: 11.205

Review 2.  In Vitro Models to Study Human Lung Development, Disease and Homeostasis.

Authors:  Alyssa J Miller; Jason R Spence
Journal:  Physiology (Bethesda)       Date:  2017-05

3.  A chemokine receptor CXCR2 macromolecular complex regulates neutrophil functions in inflammatory diseases.

Authors:  Yanning Wu; Shuo Wang; Shukkur M Farooq; Marcello P Castelvetere; Yuning Hou; Ji-Liang Gao; Javier V Navarro; David Oupicky; Fei Sun; Chunying Li
Journal:  J Biol Chem       Date:  2011-12-27       Impact factor: 5.157

4.  Does the F508-CFTR mutation induce a proinflammatory response in human airway epithelial cells?

Authors:  Thomas H Hampton; Alicia E Ballok; Jennifer M Bomberger; Melanie R Rutkowski; Roxanna Barnaby; Bonita Coutermarsh; José R Conejo-Garcia; George A O'Toole; Bruce A Stanton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-07-20       Impact factor: 5.464

5.  Regulation of gap junctional communication by a pro-inflammatory cytokine in cystic fibrosis transmembrane conductance regulator-expressing but not cystic fibrosis airway cells.

Authors:  M Chanson; P Y Berclaz; I Scerri; T Dudez; K Wernke-Dollries; L Pizurki; A Pavirani; M A Fiedler; S Suter
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

6.  Angiopoietin-1 inhibits endothelial permeability, neutrophil adherence and IL-8 production.

Authors:  Lara Pizurki; Zongmin Zhou; Konstantinos Glynos; Charis Roussos; Andreas Papapetropoulos
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

Review 7.  Dysregulated Chemokine Signaling in Cystic Fibrosis Lung Disease: A Potential Therapeutic Target.

Authors:  Xiaoqing Guan; Yuning Hou; Fei Sun; Zhe Yang; Chunying Li
Journal:  Curr Drug Targets       Date:  2016       Impact factor: 3.465

8.  TLR-4-mediated innate immunity is reduced in cystic fibrosis airway cells.

Authors:  Gerrit John; Ali O Yildirim; Bruce K Rubin; Dieter C Gruenert; Markus O Henke
Journal:  Am J Respir Cell Mol Biol       Date:  2009-06-05       Impact factor: 6.914

9.  Flagellin-stimulated Cl- secretion and innate immune responses in airway epithelia: role for p38.

Authors:  Beate Illek; Zhu Fu; Christian Schwarzer; Tina Banzon; Stephen Jalickee; Sheldon S Miller; Terry E Machen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-07-25       Impact factor: 5.464

10.  Organelle redox of CF and CFTR-corrected airway epithelia.

Authors:  Christian Schwarzer; Beate Illek; Jung H Suh; S James Remington; Horst Fischer; Terry E Machen
Journal:  Free Radic Biol Med       Date:  2007-04-29       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.